EUS引导下经针活检对胰腺囊性病变的诊断价值:一项荟萃分析
TTNB样本充足率为85.3%,诊断准确率、灵敏度和特异度分别为78.8%、82.2%和96.8%,在样本充足率和诊断准确率上均优于FNA。轻度出血和胰腺炎发生率分别为4%和2%。
要点
- TTNB样本充足率85.3%,诊断准确率78.8%,灵敏度82.2%,特异度96.8%。
- TTNB在样本充足率和诊断准确率上均显著优于FNA。
- 轻度出血和胰腺炎发生率分别为4%和2%,安全性可接受。
核心结论
- 该荟萃分析支持EUS引导下经针活检作为胰腺囊性病变组织获取的安全有效工具。
主要发现
- TTNB样本充足率为85.3%(78.2%-92.5%),按囊肿形态、大小和位置进行的亚组分析确认了该结果。
- TTNB在样本充足率(OR 4.83,95%CI 1.63-14.31,P=.004)和诊断准确率(OR 3.44,95%CI 1.32-8.96,P=.01)上均优于FNA。
- TTNB合并诊断准确率、灵敏度和特异度分别为78.8%、82.2%和96.8%。
- 获取 adequate 组织学样本平均需要3.121次(2.98-3.25)穿刺。
- 轻度出血和胰腺炎发生率分别为4%和2%。
关键数值与推荐
- 样本充足率85.3%(78.2%-92.5%)。
- 诊断准确率78.8%,灵敏度82.2%,特异度96.8%。
- 与FNA比较:样本充足率OR 4.83(95%CI 1.63-14.31,P=.004),诊断准确率OR 3.44(95%CI 1.32-8.96,P=.01)。
- 平均穿刺次数3.121(2.98-3.25)。
- 轻度出血率4%,胰腺炎发生率2%。
临床怎么用
- 对于胰腺囊性病变,EUS引导下经针活检可作为提高组织样本充足率和诊断准确率的取样方法。
- 临床操作中需注意轻度出血和胰腺炎风险,权衡获益与风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: There is currently limited evidence supporting the use of EUS-guided through-the-needle biopsy for sampling pancreatic cystic lesions. The aim of this meta-analysis was to provide a pooled estimate of the diagnostic performance of through-the-needle biopsy for sampling of pancreatic cysts. METHODS: A bibliographic search on the main databases was performed in September 2019. Pooled effects were calculated using a random-effects model by means of the DerSimonian and Laird test. The primary outcome was sample adequacy. Additional endpoints were diagnostic accuracy, optimal histologic core procurement, mean number of needle passes, pooled specificity, and sensitivity. Adverse event rates were also analyzed. RESULTS: Eleven studies enrolling 490 patients were included. Eight articles compared through-the-needle biopsy with cytology/cystic fluid analysis. Most patients were female, and the body/tail was the most frequent location of cystic lesions. Sample adequacy with through-the-needle biopsy was 85.3% (78.2%-92.5%), and subanalysis performed according to cyst morphology, size, and location confirmed the result. Through-the-needle biopsy clearly outperformed FNA both in terms of sample adequacy (odds ratio, 4.83; 95% confidence interval, 1.63-14.31; P =.004) and diagnostic accuracy (odds ratio, 3.44; 95% confidence interval, 1.32-8.96; P =.01). The pooled diagnostic accuracy rate, sensitivity, and specificity of through-the-needle biopsy were 78.8%, 82.2%, and 96.8%, respectively. A mean of 3.121 (2.98-3.25) passes through the cyst was needed to obtain adequate histologic samples. The incidence rates of mild bleeding and pancreatitis were 4% and 2%, respectively. CONCLUSION: Our meta-analysis speaks in favor of the use of through-the-needle biopsy as a safe and effective tool in EUS-guided tissue acquisition of pancreatic cysts.
引用
- Facciorusso A, Del Prete V, Antonino M, et al. Diagnostic yield of EUS-guided through-the-needle biopsy in pancreatic cysts: a meta-analysis. Gastrointest Endosc. 2020. PMID: 32014422. doi:10.1016/j.gie.2020.01.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。